Antiplatelet Therapy in Cardiovascular Disease (Q168211): Difference between revisions

From geokb
(‎Changed label, description and/or aliases in en, and other parts: modified description with assistance from Llama 3.1)
(‎Changed label, description and/or aliases in en, and other parts: removed aliases from OpenAlex topic and added addresses subject claims to linkable items)
 
(One intermediate revision by the same user not shown)
aliases / en / 0aliases / en / 0
Aspirin
aliases / en / 1aliases / en / 1
Clopidogrel
aliases / en / 2aliases / en / 2
Ticagrelor
aliases / en / 3aliases / en / 3
Platelet Reactivity
aliases / en / 4aliases / en / 4
Cardiovascular Events
aliases / en / 5aliases / en / 5
Percutaneous Coronary Intervention
aliases / en / 6aliases / en / 6
Genetic Polymorphisms
aliases / en / 7aliases / en / 7
Bleeding Risk
aliases / en / 8aliases / en / 8
Thrombotic Events
aliases / en / 9aliases / en / 9
CYP2C19 Genotype
Property / same as
 
Property / same as: https://openalex.org/T11064 / rank
Normal rank
 
Property / OpenAlex ID
 
Property / OpenAlex ID: T11064 / rank
 
Normal rank

Latest revision as of 20:45, 21 September 2024

Preventing cardiovascular events with medications that stop platelets from clotting.
Language Label Description Also known as
English
Antiplatelet Therapy in Cardiovascular Disease
Preventing cardiovascular events with medications that stop platelets from clotting.

    Statements